Home · Peptides · Bronchogen
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Bronchogen

THE LUNG RESTORER

AEDL peptide

Bronchogen is a short peptide (AEDL) from the Khavinson family designed to support respiratory health. It works by modifying gene expression in lung tissue, helping restore the epithelial lining, reduce inflammation, and improve surfactant production. It's studied for COPD, chronic bronchitis, and age-related lung decline.

Bronchogen
Bronchogen
Bronchogen

Bronchogen Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

May 8, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Bronchogen

◆

Is Bronchogen FDA approved?

No. This profile records Bronchogen as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Bronchogen?

Dose: 750 mcg daily.

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 8 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Bronchogen guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Epigenetic Regulation

Binds DNA to modify gene expression in lung tissue

Anti-Inflammatory

Reduces pro-inflammatory cytokines (TNF-α, IL-6)

Epithelial Repair

Restores bronchial lining and mucosal barrier function

Surfactant Production

Enhances lung surfactant for better gas exchange

People with COPD or chronic bronchitis
Smokers or former smokers
Those recovering from respiratory infections
Aging individuals with declining lung function
Anyone exposed to environmental pollutants

Bronchogen Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.